Publications: Rodrigo Balbontin

ITIF urges USTR to continue to use the NTE report to hold trading partners accountable. To that end, ITIF recommends adding a separate section in the report outlining non-tariff attacks (NTAs).

The Commission should organize Diversify EU around allied production capacity and a coordinated response to Chinese mercantilism.

KFTC enforcement data suggests de facto bias against leading American technology companies. Given this record, U.S. policymakers should demand fair treatment for U.S. firms, and South Korean policymakers should reconsider expanding the KFTC’s authority over online platforms.

As AI demand drives memory chip prices to more than triple in 2026, Washington should resist short-term fixes that pick who gets scarce supply or deepen reliance on Chinese producers and instead expand U.S. memory production capacity for the long term.

Foreign online piracy causes significant economic harm to U.S. creative industries, yet American courts lack the authority to block foreign pirate sites. Congress should adopt carefully designed site-blocking legislation that targets large-scale piracy while minimizing the risk of overblocking.

China has consistently failed to meet its WTO commitments, continuing to harm U.S. competitiveness. In response, Congress and the USTR should prepare a phased, strategic pathway to revoke China's Permanent Normal Trade Relations (PNTR) status if Beijing refuses to reform.

As U.S.-Canada trade tensions escalate, both countries risk weakening the North American production base they need to compete with China—and turning a manageable dispute into a costly, self-defeating trade war.

A survey among 32 think tank members of the Global Trade and Innovation Policy Alliance (GTIPA) across 25 countries finds strong optimism about technological progress, but much less confidence in the global policy environment. Respondents are bullish on emerging technologies and skeptical of recent trade changes, and broadly favor skills and trade openness.

Instead of copying other OECD countries in a “reference-price-race-to-the-bottom,” U.S. policy should instead encourage peer countries to appropriately value innovative medicines.

The era of free trade globalization is over. To replace it, the United States should lead a new class of binding deals with allies, with a dual objective of strengthening allied national economic power industries and weakening China’s.